World Radiation Therapy Equipment Industry

LONDON, Feb. 5, 2015 — (PRNewswire) — This report analyzes the worldwide markets for Radiation Therapy Equipment in US$ Million by the following Product Segments: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 48 companies including many key and niche players such as -

Accuray Incorporated
Elekta AB
GE Healthcare
Hitachi America

Download the full report:

Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Linear Accelerator I-3
Treatment Planning System I-4
Radiation Therapy Simulator I-4


Global Market for Radiotherapy - A Synopsis II-1
Radiation Therapy Equipment and Software Market Bounces Back
from Recession II-2
Table 1: Healthcare Spending as a Percentage of GDP in Select
Countries (includes corresponding Graph/Chart) II-3

Table 2: Per-Capita Healthcare Expenditure in Select Regions
(2013) (includes corresponding Graph/Chart) II-4
Current and Future Analysis II-5
North America - The Most Advanced and Dominant Global Market
for Radiotherapy II-6
US Leads in Penetration of LINACs II-6
Table 3: Installed Base of Linacs Per Million Inhabitants
for Select Geographic Regions/ Countries (2013) (includes
corresponding Graph/Chart) II-7
Developing Nations Offer Lucrative Opportunities II-8
Table 4: Top 20 Countries with the Highest Healthcare
Spending as a Percentage of GDP (2012) (includes
corresponding Graph/Chart) II-9
Asia-Pacific - A Highly Promising Market II-9

Expanding Aging Population Raises Risk of Cancer, Drives
Demand for Radiation Therapy Solutions II-11
Table 5: Global Population Statistics for the 65+ Age Group
(2013) (includes corresponding Graph/Chart) II-12

Table 6: Elderly Population (60+ Years) as a Percentage of
the Total Population (2012 & 2050) (includes corresponding
Graph/Chart) II-13

Table 7: Life Expectancy at Age 60 and 80 Years -
(2010-2015), (2020-2025) & (2045-2050) (includes
corresponding Graph/Chart) II-13
Replacement Sales Drive Radiotherapy Market in Developed Markets II-14
Table 8: Percentage of Patients Provided Radiation Therapy in
Developed Markets (2013) (includes corresponding Graph/Chart) II-15

Table 9: Global Installed Base of LINACs (2013): Percentage
Share Breakdown by Volume of Units Installed for North
America, Europe, Asia Pacific (Including Japan) & Middle
East, South America, and Africa (includes corresponding
Graph/Chart) II-15
Improving Healthcare Expenditure Turbo Charges Demand II-16
Table 10: Per-Capita Healthcare Expenditure in Select Regions
(2013) (includes corresponding Graph/Chart) II-16
External Beam Radiation Therapy Equipment Corners Lion's Share
of Market II-17
Table 11: Global Radiation Therapy Equipment Market by Type
(2014): Market Share Breakdown of Sales Revenues for External
Beam Radiation Therapy (EBRT), Brachytherapy, and Others
(includes corresponding Graph/Chart) II-17
LINACS Increasingly Replace Conventional Equipment II-17
Demand for Oncology Information Systems (OIS) on Rise II-18
Data-Intensive Radiation Oncology Promotes OIS Connection to
EHRs II-18
Treatment Planning - Grows in Significance II-19
Need for Boosting Productivity of Existing Cancer Care Centers
Drives Demand for New Technologies II-19
Technological Innovations Improve Treatment Accuracy II-20
Personalized Radiation Therapy - The Way Forward II-20
Hospitals Focus on Buying IMRT-Capable LINACs II-21
Types of IMRT II-22
Rotational IMRT Gains Popularity II-22
Stereotactic Radio Surgery - A Treatment with Rising Preference II-22
Adaptive Radiation Therapy (ART) Gains Significance II-23
IGRT Gaining Ground II-23
Shortage of Medical Professionals & Systems - A Major Obstacle II-24
Patient Comfort - A Significant Concern Affecting Treatment
Accuracy II-24

Proton Therapy - Revolutionizing the Industry II-25
Table 12: World Recent Past, Current & Future Analysis for
Proton Therapy by Geographic Region - US, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) II-26

Table 13: World 7-Year Perspective for Proton Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
US, Japan, Europe, Asia-Pacific (excluding Japan), and Rest
of World Markets for Years 2014 & 2020 (includes
corresponding Graph/Chart) II-27
IMPT - The Future of Proton Therapy II-27
High Cost - A Barrier to Adoption II-28
Technological Advancement to Lower Cost of Therapy II-28

Competitive Landscape II-29
Table 14: Leading Global Players in Radiation Therapy
Equipment Market (2013): Percentage Share Breakdown by Sales
for Varian, Elekta, Accuray, Siemens, and Others (includes
corresponding Graph/Chart) II-30
Exit of Siemens Healthcare Opens Doors for Windfall Gains II-30
Table 15: Siemens Healthcare Worldwide Installed Base of
Linear Accelerators (2013) (includes corresponding
Graph/Chart) II-31
Competition in the LINAC Segment II-31
Table 16: Leading Players in Global LINAC Market (2012):
Percentage Share Breakdown by Volume of Units Installed for
Varian, Elekta, Siemens and Others (includes corresponding
Graph/Chart) II-32
Stereotactic Radiosurgery Systems (SRS) - Market Scenario II-32
Table 17: Leading Players in SRS/SBRT Market (2013):
Percentage Share Breakdown by Volume Sales for Elekta,
BrainLab, Accuray and Others (includes corresponding
Graph/Chart) II-32
Proton Therapy Equipment Market Marked by Intense Competition II-32
Table 18: Leading Global Players in Proton Therapy Market
(2013): Percentage Share Breakdown by Operational Installed
Base for IBA, Hitachi, Mitsubishi, Varian and Sumitomo
(includes corresponding Graph/Chart) II-33
Competitive Landscape in Treatment Planning Systems Market II-33
Table 19: Global Treatment Planning Systems Market by
Leading Players (2013): Market Share Breakdown for Installed
Base for Elekta/Nucletron, Philips, Varian and Others
(includes corresponding Graph/Chart) II-34

Cancer Incidence - Statistics on New Cases II-35
Table 20: Worldwide Incidence of Cancer (2013, 2020 & 2030):
Number of New Cases Diagnosed (includes corresponding
Graph/Chart) II-35

Table 21: New Cancer Cases in the World by Affected Site:
2012 (in Thousands) (includes corresponding Graph/Chart) II-36

Table 22: Global Cancer Incidence by Income Group: 2012 (in
Thousands) (includes corresponding Graph/Chart) II-37

Table 23: Cancer Incidence in High Income Countries by Site:
2012 (in Thousands) (includes corresponding Graph/Chart) II-37

Table 24: Cancer Incidence in Upper Middle Income Countries
by Site: 2012 (in Thousands) (includes corresponding
Graph/Chart) II-38

Table 25: Cancer Incidence in Lower Middle Income Countries
by Site: 2012 (in Thousands) (includes corresponding
Graph/Chart) II-39

Table 26: Cancer Incidence in Low Income Countries by Site:
2012 (in Thousands) (includes corresponding Graph/Chart) II-40
Cancer Incidence in Developing Countries II-40
Cancer in Asia II-41
Cancer Cases - Mortality Rates II-41

Radiation Therapy - A Panacea for all Cancer Diseases II-42
Milestones in Evolution of Cancer Care Technologies II-43
Treatment Scenario II-43
Table 27: Major Body Sites for Administration of
Radiotherapy: Percentage Breakdown of Frequency of
Application of Radiation Treatment for Breast, Prostate,
Lung, Head & Neck, and Other Body Sites (includes
corresponding Graph/Chart) II-44
Radiation Therapy Treatment Team II-44
Types of Radiation Therapy II-44
External Beam Radiation Therapy (EBRT/XRT) or Teletherapy II-45
Conventional External Beam Radiotherapy II-45
Stereotactic Radiation II-45
Particle Therapy or Proton Therapy II-45
Auger Therapy II-46

1 | 2 | 3 | 4 | 5 | 6  Next Page »

Review Article Be the first to review this article
Kenesto: 30 day trial

© 2017 Internet Business Systems, Inc.
25 North 14th Steet, Suite 710, San Jose, CA 95112
+1 (408) 882-6554 — Contact Us
ShareCG™ is a trademark of Internet Business Systems, Inc.

Report a Bug Report Abuse Make a Suggestion About Privacy Policy Contact Us User Agreement Advertise